Navigation Links
The 'disinhibited' brain
Date:9/21/2011

The Complex Regional Pain Syndrome (CRPS), also known as Morbus Sudeck, is characterised by "disinhibition" of various sensory and motor areas in the brain. A multidisciplinary Bochum-based research group, led by Prof. Dr. Martin Tegenthoff (Bergmannsheil Neurology Department) and Prof. Dr. Christoph Maier (Bergmannsheil Department of Pain Therapy), has now demonstrated for the first time that with unilateral CRPS excitability increases not only in the brain area processing the sense of touch of the affected hand. In addition, the brain region representing the healthy hand is simultaneously "disinhibited". The group has been performing research on and treatment of CRPS for a number of years. The researchers are reporting the new findings in the renowned journal Neurology. The study was supported by the Research Funds of the Deutsche Gesetzliche Unfallversicherung (DGUV).

Is there a predisposition for CRPS?

CRPS can develop after even slight injuries and often leads to long-lasting severe pain, impairment of sensation and movement, as well as changes to the skin and the bones of the affected extremity - in many cases it even causes permanent disability. The precise cause of the syndrome is not known. Alongside inflammatory phenomena, changes in the brain also contribute to the disease becoming chronic. "Although the symptoms are mainly limited to one side of the body, some changes in the brain appear to affect both sides - a finding which could hint at an individual predisposition for the development of CRPS", says Prof. Martin Tegenthoff.

Faulty programming in the brain

As yet, the origins of the disease remain largely unclear. Pain researchers assume that not only inflammatory factors, but also changes in the central nervous system may be a possible cause. For example, in a number of studies researchers found the representation of the affected hand on the brain's "body map" to have shrunk, a phenomenon closely associated with the patients' pain intensity and tactile discrimination abilities.

Excitability changes on both sides

In a previous study, the Bochum group already made an astonishing discovery in the motor system of CRPS patients: the excitability of their motor hand area in the brain is increased - not only in the half of the brain controlling the affected side, but also in the half correlating to the healthy side. Following these findings hinting at a systemic disorder of the central nervous system, in the current study the group examined whether bilateral disinhibition can also be found in the brain area processing the sense of touch (somatosensory cortex). CRPS patients with unilateral symptoms of the hand were examined. After an electrical stimulation, the researchers measured the brain waves in the somatosensory brain area of the affected and the unaffected hand. Results show: the reduction of inhibition which is found on both sides in CRPS is not limited to motor areas. Those areas of the brain that process sensory perception of the hands exhibit distinct changes too.

"Disinhibition": typical of neuropathic pain

The scientists validated these findings by comparing CRPS patients with healthy volunteers and with patients suffering from pain that in contrast to CRPS was not caused by a disease of the nerves (so-called non-neuropathic pain). Here too, the researchers found an amazing result: the control patients showed no altered inhibition whatsoever in the hand area, they did not differ from the healthy volunteers. "This shows that the disinhibition of the brain in CRPS patients appears to be specific for neuropathic pain", says Prof. Tegenthoff.

Systemic changes raise questions

The results indicate that the changes in the central nervous system caused by CRPS are much more complex than scientists have assumed up to now. Bilateral changes in the central sensorimotor systems that manifest in unilateral symptoms raise questions - for example: are they a cause or a consequence of the disease? The RUB scientists are presently undertaking a first approach at answering this question: in a long-term study they will accompany the patients to perform two further measurements in intervals of six months between dates. In this way, they can relate potential changes in the brain to the healing process. If a successful therapy reverses these changes, they are most probably a consequence of the disease.

Factoring in the brain

"Our research results make clear that changes in the brain play a prominent role in CRPS", says Prof. Dr. Christoph Maier. "As we already do in current pilot studies performed in the Department of Pain Therapy at Bergmannsheil, future therapies should take this aspect into account, in order to improve the treatment of what continues to be a problematic illness."


'/>"/>

Contact: Dr. Martin Tegenthoff
martin.tegenthoff@rub.de
49-234-302-6810
Ruhr-University Bochum
Source:Eurekalert

Related medicine news :

1. Buyer beware: Advertising may seduce your brain, UCLA researchers say
2. Key regulatory genes often amplified in aggressive childhood tumor of the brainstem
3. More than a sign of sleepiness, yawning may cool the brain
4. Brains of Obese May Crave High-Calorie Foods More: Study
5. Negative emotions influence brain activity during anticipation and experience of pain
6. Pediatric brain tumors
7. MRI research demonstrates ALS attacks multiple parts of the brain
8. T cells making brain chemicals may lead to better treatments for inflammation, autoimmune diseases
9. Problem Drinking Linked to Brain Damage
10. Starving cancer cells of cholesterol might offer a new way to treat brain tumors
11. Targeting cholesterol to fight deadly brain cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... 2017 , ... The Topricin Companies, formerly Topical Biomedics, is ... natural, after-burn skin care product, Topricin After Burn Cream. , Overexposure ... conditions, including cancer. In the short term, overexposure to sun, wind and ...
(Date:7/24/2017)... Beach, California (PRWEB) , ... July 24, 2017 ... ... commercialization of autologous fat (adipose) transfer systems announces the issuance of United States ... ‘324 patent) for its adipose filtration technology. The '398 and '324 patents ...
(Date:7/24/2017)... ... July 24, 2017 , ... Sharon Kleyne, host of the ... Health on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked on the air about ... in China. , The article by Zidor Aldama described the situation in which Chinese ...
(Date:7/24/2017)... ... July 24, 2017 , ... A Southern California-based author has released a ... and how she has overcome them. “Forbidden Memories: A Memoir,” by author Michelle V. ... she has risen above. , In “Memories,” readers get a firsthand look at what ...
(Date:7/24/2017)... Huntingdon Valley, PA (PRWEB) , ... July 24, 2017 , ... ... wind and rain storms wreak havoc across communities and often result in massive tree ... Top 3 actions homeowners can take now including tree trimming, tree cabling and hazardous ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... -- New York City-based market research firm Kalorama Information notes seven ... From new products to new costs, to the threat of ... study, Potential Pipeline Disruptors . Among them ... 1.  Age-Driven Growth - True Impact Moment Arriving   ... the growing population and, to a more extreme extent, the ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... Administration (FDA) has agreed to schedule an End-of-Phase II ... trial of its oral insulin capsule ORMD-0801 in the ... met primary and secondary endpoints by indicating a statistically ...
Breaking Medicine Technology: